Author

Jaspreet Singh

Henry Ford HealthORCID 0000-0002-6563-5424Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jaspreet Singh1 paper · Simons Foundation

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1

Frequent Co-Authors

Laila PoissoniD· 2 shared Navtej Kaur· 2 shared Ashok KumariD· 1 shared Ashutosh Kumar MangalamiD· 1 shared Bin RuiiD· 1 shared Faraz RashidiD· 1 shared Hamid Suhail· 1 shared Indrani DattaiD· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Laila PoissonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes

Navtej Kaur, Jaspreet Singh

The paper generates iPSC-derived astrocytes from AMN and cALD patients to model X-ALD phenotypes and study disease mechanisms.

bioRxiv · May 31, 2024 · PreprintNeuroscience

iPSC-derived astrocytes to model phenotype-specific differential neuroinflammatory and metabolic responses in X-linked adrenoleukodystrophy

Parveen Parasar, Navtej Kaur, Laila Poisson, Jaspreet Singh

This study uses iPSC-derived astrocytes to compare metabolic and inflammatory responses between AMN and cALD phenotypes in X-ALD, identifying miR-9 as associated with disease severity.

bioRxiv · Sep 9, 2022 · PreprintNeuroscience

Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic target

Insha Zahoor, Hamid Suhail, Indrani Datta, Mohammad Ejaz Ahmed, Laila Poisson, Jeffrey Waters, Faraz Rashid, Bin Rui, Jaspreet Singh, Mirela Cerghet, Ashok Kumar, Md Nasrul Hoda, Ramandeep Rattan, Ashutosh Kumar Mangalam, Shailendra Giri

The paper identifies altered metabolic pathways in RRMS patients using metabolomics and shows that targeting glycolysis can reduce disease progression in a mouse model.

Proceedings of the National Academy of Sciences · Jun 14, 2022Peer-reviewedNeuroscience